Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

NCT02892344 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

802

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Asthma

Interventions

DRUG: QMF149 150/80 μg
DRUG: MF 200 μg

Sponsor

Novartis Pharmaceuticals